Not applicableStudy completedNCT00783510What this trial is testingJuvenile Idiopathic Arthritis (JIA) RegistryWho this might be right forJuvenile Idiopathic ArthritisJIA AbbVie 849
Early research (Phase 1)Study completedNCT01904279What this trial is testingSubcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)Who this might be right forJuvenile Idiopathic Arthritis Hoffmann-La Roche 52
Large-scale testing (Phase 3)Looking for participantsNCT07554495What this trial is testingSafety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and AdolescentsWho this might be right forPolyarticular Course Juvenile Idiopathic Arthritis Alfasigma S.p.A. 65
Early research (Phase 1)Study completedNCT02165345What this trial is testingExtension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic ArthritisWho this might be right forJuvenile Idiopathic Arthritis Hoffmann-La Roche 82
Large-scale testing (Phase 3)Study completedNCT01835470What this trial is testingEfficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in JapanWho this might be right forJuvenile Idiopathic Arthritis Bristol-Myers Squibb 23
Large-scale testing (Phase 3)Study completedNCT01667471What this trial is testingA Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core StudyWho this might be right forJuvenile Idiopathic Arthritis Hoffmann-La Roche 6
Large-scale testing (Phase 3)Study completedNCT02592434What this trial is testingEfficacy Study Of Tofacitinib In Pediatric JIA PopulationWho this might be right forJuvenile Idiopathic Arthritis Pfizer 225
Large-scale testing (Phase 3)Looking for participantsNCT06654882What this trial is testingTrial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisWho this might be right forPolyarticular Course Juvenile Idiopathic Arthritis (JIA) Duke University 400
Not applicableEnded earlyNCT01557452What this trial is testingOpen-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic ArthritisWho this might be right forJuvenile Idiopathic Arthritis Italfarmaco 1
Large-scale testing (Phase 3)Ended earlyNCT01575769What this trial is testingAn Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic ArthritisWho this might be right forJuvenile Idiopathic Arthritis Hoffmann-La Roche 41
Testing effectiveness (Phase 2)Ended earlyNCT01261624What this trial is testingEfficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic ArthritisWho this might be right forPolyarticular Course Juvenile Idiopathic Arthritis Italfarmaco 16
Large-scale testing (Phase 3)Study completedNCT00988221What this trial is testingTocilizumab in Patients With Active Polyarticular Juvenile Idiopathic ArthritisWho this might be right forJuvenile Idiopathic Arthritis Hoffmann-La Roche 188
Large-scale testing (Phase 3)Study completedNCT01727986What this trial is testingAn Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 StudyWho this might be right forJuvenile Idiopathic Arthritis Hoffmann-La Roche 11
Large-scale testing (Phase 3)Study completedNCT02277444What this trial is testingEvaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate TherapyWho this might be right forArthritis, Juvenile Janssen Research & Development, LLC 130
Large-scale testing (Phase 3)Ended earlyNCT03781375What this trial is testingEtanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid ArthritisWho this might be right forJuvenile Rheumatoid Arthritis Amgen 25
Early research (Phase 1)Active Not RecruitingNCT03725007What this trial is testingEvaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic ArthritisWho this might be right forJuvenile Idiopathic Arthritis (JIA) AbbVie 124
Large-scale testing (Phase 3)Study completedNCT01550003What this trial is testingPediatric Arthritis Study of Certolizumab PegolWho this might be right forPolyarticular-course Juvenile Idiopathic Arthritis (JIA) UCB BIOSCIENCES GmbH 193
Testing effectiveness (Phase 2)Study completedNCT00037648What this trial is testingJuvenile Rheumatoid ArthritisWho this might be right forJuvenile Chronic Arthritis Amgen 86
Testing effectiveness (Phase 2)Study completedNCT02776735What this trial is testingAn Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)Who this might be right forJuvenile Idiopathic Arthritis Sanofi 102
Large-scale testing (Phase 3)Study completedNCT01673919What this trial is testingA Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core StudyWho this might be right forJuvenile Idiopathic Arthritis Hoffmann-La Roche 7